Parameters governing exhaustion of rare T cell-independent neutralizing IgM-producing B cells after LCMV infection

European Journal of Immunology

Volumn 36, Issue 12, 2006, Pages 3175-3185

  Zellweger, Raphaël M ^a   Hangartner, Lars ^b   Weber, Jacqueline ^a   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

B lymphocytes; LCMV; Neutralizing antibody

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HELPER CELL; HUMORAL IMMUNITY; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; B-LYMPHOCYTE SUBSETS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTRALIZATION TESTS; RATS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 33845563842     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636087     Document Type: Article

References (25)

1. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R. et al., Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994. 369: 31-37.
2. Battegay, M., Moskophidis, D., Waldner H., Brundler, M. A., Fung-Leung, W. P., Mak, T. W., Hengartner, H. and Zinkernagel, R. M., Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J. Immunol. 1993. 151: 5408-5415.
3. Planz, O., Ehl, S., Furrer, E., Horvath, E., Brundler, M. A., Hengartner, H. and Zinkernagel, R. M., A critical role for neutralizing-antibody-producing B cells, CD4(+)T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 1997. 94: 6874-6879.
4. Thomsen A. R. and Marker, O., The complementary roles of cellular and hummoral immunity in resistance to re-infection with LCM virus. Immunology 1988. 65: 9-15.
5. Koup, R. A., Safrit, J. T., Can, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immuno-deficiency virus type 1 syndrome. J. Virol. 1994. 68: 4650-4655.
6. Shata, M. T., Anthony, D. D., Carlson, N. L., Andrus, L, Brotman, B., Tricoche, N., McCormack, P. and Prince, A., Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. J. Viral Hepat. 2002. 9: 400-410.
7. Althage, A., Odermatt, B., Moskophidis, D., Kundig, T., Hoffman-Rohrer, U., Hengartner, H. and Zinkernagel, R. M., immunosuppression by lymphocytic choriomeningitis virus infection: Competent effector T and B cells but impaired antigen presentation. Eur. J. Immunol. 1992. 22: 1803-1812.
8. Odermatt, B., Eppler, M., Leist, T. P., Hengartner, H. and Zinkernagel, R. M., Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl. Acad. Sci. USA 1991. 88: 8252-8256.
9. Pinschewer, D. D., Perez, M., Jeetendra, E., Bachi, T., Horvath, E., Hengartner, H., Whitt, M. A. et al., Kinetics of protective antibodies are determined by the viral surface antigen. J. Clin. Invest 2004. 114: 988-993.
10. Recher, M., Lang, K. S., Hunziker, L., Freigang, S., Eschli, B., Harris, N. L., Navarini, A. et al., Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat. Immunol. 2004. 9: 934-42.
11. Hangartner, L., Senn, B. M., Ledermann, B., Kalinke, U., Seiler, P., Bucher, L., Zellweger, R. M. et al., Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies. Proc. Natl. Acad. Sci USA 2003. 100: 12883-12888.
12. Klenerman, P., Commentary: T cells get by with a little help from their friends. Eur. J. Immunol. 2004. 34: 313-316.
13. Ou, R., Zhou, S., Huang, L. and Moskophidis, D., Critical role for alpha/ beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 2001. 75: 8407-8423.
14. Oxenius, A., Bachmann, M. F., Zinkernagel, R. M. and Hengartner, H., Virus-specific MHC-class II-restricted TCR-transgenic mice: Effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 1998. 28: 390-400.
15. Probst, H. C., Tschannen, K., Gallimore A., Martinic, M., Basler, M., Dumrese, T., Jones, E. and van den Broek, M. F., Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 2003. 171: 5415-5422.
16. Garcia de Vinuesa, C.,O'Leary, P., Sze, D. M,, Toellner, K. M. and MacLennan, L. C., T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur. J. Immunol. 1999. 29: 1314-1323.
17. Linton P. L., Decker, D. J. and Klinman, N. R., Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations. Cell 1989. 59: 1049-1059.
18. Castigli, E., Wilson S. A., Scott, S., Dedeoglu, F., Xu, S., Lam, K. P., Bram, R. J. et al., TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 2005. 201: 35-39.
19. MacLennan I. and Vinuesa, C., Dendritic cells, BAFF, and APRIL: Innate players in adaptive antibody responses. Immunity 2002. 17: 235-238.
20. Pasare, C. and Medzhitov, R., Control of B-cell responses by Toll-like receptors. Nature 2005. 438: 364-368.
21. Hangartner, L., Zinkernagel, R. M. and Hengartner, H.. Antiviral antibody responses: The two extremes of a wide spectrum Nat. Rev. Immunol. 2006. 6: 231-243.
22. Zinkernagel, R. M., on natural and artificial vaccinations. Annu. Rev. Immunol. 2003. 21: 515-546.
23. Cobbold, S., Martin, G. and Waldmann, H., Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo. Transplantation 1986. 42: 239-247.
24. Battegay, M, Cooper, S., Althage, A.. Banziger, J., Hengartner, H. and Zinkernagel, R. M., Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates [published errata appear in J. Virol. Methods 1991, 35, 115 and 1992, 38, 263]. J. Virol. Methods 1991. 33: 191-198.
25. Battegay, M., Kyburz, D., Hengartner, H. and Zinkernagel, R. M., Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T Cells. Eur. J. Immunol. 1993. 23: 3236-3241.